ArticleJournal of clinical case reports2017

Rituximab as First-Line Therapy in Severe Lupus Erythematosus with Neuropsychiatric and Renal Involvement: A Case-Report and Review of the Literature.

Andrea Angeletti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.